Navigation Links
ACORN Expands Presence in EDC Market with Commercialization of Guardian EDC(TM)
Date:5/14/2008

MEMPHIS, Tenn., May 14 /PRNewswire/ -- Accelerated Community Oncology Research Network(TM) (ACORN), an oncology-focused CRO and research network, announced today that it is making its Electronic Data Capture (EDC) system, Guardian EDC(TM), commercially available. This proprietary system will be available for all studies, including those outside of oncology. Previously, Guardian EDC (TM) has only been available to studies within the ACORN clinical trial portfolio.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO )

"Since its deployment, the web-based Guardian EDC(TM) has been used in multiple industry-sponsored trials, investigator initiated trials, and large observational trials," according to Ed Stepanski, Chief Operating Officer. "We believe Guardian provides an extremely secure, functional, and economically attractive EDC alternative to pharmaceutical sponsors and CROs in both oncology and other medical specialties."

Guardian EDC(TM) satisfies and or surpasses all applicable FDA regulations, including 21 CFR Part 11. Among its more significant features are automatic randomization; full on-screen audit trail capability, providing user identification, date, time and reason for edit; auto-generating reports; and electronic principal investigator signatures. For convenience, Guardian EDC(TM) provides extensive study amendment capabilities.

"In the development process we analyzed the strengths and weaknesses of all the EDCs our network worked with over the last 5 years," according to Bridget Rose, Guardian EDC(TM) Project Leader. "We then designed a system which meets the demanding needs of oncology clinical research and are quite pleased with the end product. Guardian has proven to be a critical component of our successful clinical trial program."

Guardian EDC(TM) enhances study efficiencies for both industry sponsors and participating practices. It places study information at the fingertips of users in one centralized location with the ability to drill down to minute detail. User-friendly, intuitive navigation virtually eliminates any learning curve and has been responsible for high user acceptance ratings.

"Having experience with multiple systems, we have found Guardian to be the most straightforward, user friendly EDC our practice has used," according to Lynn Kaplan, research coordinator with Tri-County Hematology & Oncology Associates in Canton, Ohio. "It's obvious, careful review and planning went into the development of this EDC by people doing quality clinical research."

Davis Templeton, CMO, is leading commercialization efforts for Guardian EDC(TM) and can be reached at dtempleton@sosacorn.com or 720-304-6536. Guardian EDC(TM) will also be demonstrated at the upcoming DIA annual meeting in Boston, June 22-26.

Accelerated Community Oncology Research Network, Inc. (ACORN)

ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Clinical Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Contact Information:

Liz Conway

(901) 435-5570

lconway@sosacorn.com

http://www.ACORNresearch.net

Deborah D. Coble

901-683-0055x1312

Cell: 901-831-1010

dcoble@sosacorn.com


'/>"/>
SOURCE Accelerated Community Oncology Research Network
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study
2. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
3. Rohm and Haas Expands in India
4. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
5. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
6. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
7. Specialty Blades, Inc. Expands Management Team With New VP Engineering
8. CRH Medical expands Las Vegas operations
9. US Med-Equip Expands Corporate Support Center
10. ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
11. Bipartisan Bill Expands Health Care Access for Small Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... Ultimate ... K-20 Education Summit to be held March 23-25, 2017 in Tampa, and reminded ... 2017. , The keynote speakers include Dr. Michelle R. Weise, executive director of ...
(Date:1/23/2017)... ... January 23, 2017 , ... Sharon Kleyne, America’s leading water ... educate listeners about the benefits of making new water infrastructure a number one priority. ... appropriate that we expect water infrastructure to become a top priority of our new ...
(Date:1/23/2017)... ... January 23, 2017 , ... Steviva Ingredients, makers of all-natural ... USDA National Organic Program (NOP) for its Portland SQF Level 2 manufacturing facility. ... and handling systems to complement our current rigorous food-safety management systems,” said Yishu ...
(Date:1/23/2017)... ... ... a story of love and redemption, hope and uncertainty as a girl makes her ... Inn at the Mill” is the creation of published author, Lois Kulp, who was born ... Berks County on Crow Hill. The inn, the mill and "Post Yokel" are ...
(Date:1/23/2017)... , ... January 23, 2017 , ... Valentine’s Day is a time when many people ... ones. For those who may be looking for the ideal present, Atlanta-based Perimeter Plastic ... get an additional $25 free. Or, spend $200 and get $50 free. , “A ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , January 20, 2017 According to ... (Descriptive, Prescriptive), Application (Marketing, R&D, Compliance, SCM), Component (Software, Service), Delivery ... Forecasts to 2021" published by MarketsandMarkets, the market is expected to ... 2016, at a CAGR of 13.3% during the forecast period. ... ...
(Date:1/21/2017)... Mass. , Jan. 20, 2017 /PRNewswire/ ... Keystone Symposia Conference, "PI3K Pathways in Immunology, ... Inc. (NASDAQ: INFI ) ... immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase-gamma ... able to help overcome resistance to checkpoint ...
(Date:1/21/2017)... , Jan. 20, 2017  Faruqi & Faruqi, LLP, ... Inc. ("KemPharm" or the "Company") (NASDAQ: KMPH ) ... Company and certain officers and directors and underwriters of the ... seek the role of lead plaintiff. The lawsuit ... District Court for Johnson County on ...
Breaking Medicine Technology: